Compare
Bioforce Nanosciences Holdings, Inc. vs Lifeloc Technologies, Inc vs Scientific Industries Inc vs Astrotech Corp
| Latest fiscal year | Bioforce Nanosciences Holdings, Inc. BFNH | Lifeloc Technologies, Inc LCTC | Scientific Industries Inc SCND | Astrotech Corp ASTC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | n/a | $9.03M | $5.05M | $913.0K |
| Revenue growth (YoY) | n/a | +5.7% | +5.4% | -13.0% |
| Gross margin | n/a | 40.3% | 25.8% | 23.8% |
| Operating margin | n/a | -13.6% | -156.1% | n/m |
| Net margin | n/a | -27.4% | -24.1% | n/m |
| Net income | -$1.29M | -$2.47M | -$1.22M | -$14.43M |
| EPS (Diluted) | -$0.04 | -$0.90 | -$0.11 | n/a |
| Operating cash flow | -$65.2K | -$499.3K | -$8.15M | -$13.45M |
| Free cash flow | n/a | -$962.1K | -$8.21M | -$14.33M |
| Cash & equivalents | $786 | n/a | n/a | $8.39M |
| Total assets | $786 | $6.69M | $12.61M | $20.51M |
| Total liabilities | $619.3K | $2.58M | $1.94M | $4.33M |
| Shareholders' equity | -$618.5K | $4.10M | $10.66M | $16.17M |
| Return on year-end equity | n/a | -60.2% | -11.4% | -89.2% |
| Shares outstanding | 33.52M | 2.75M | 11.93M | 2.00M |
Revenue, most recent five fiscal years
| Fiscal year | Bioforce Nanosciences Holdings, Inc. | Lifeloc Technologies, Inc | Scientific Industries Inc | Astrotech Corp |
|---|---|---|---|---|
| Latest | $17.8K Ended 2019-12-31 | $9.03M Ended 2025-12-31 | $5.05M Ended 2025-12-31 | $913.0K Ended 2026-06-30 |
| 1 year earlier | $16.3K Ended 2018-12-31 | $8.54M Ended 2024-12-31 | $4.80M Ended 2024-12-31 | $1.05M Ended 2025-06-30 |
| 2 years earlier | $4.5K Ended 2017-12-31 | $9.33M Ended 2023-12-31 | $11.11M Ended 2023-12-31 | $1.66M Ended 2024-06-30 |
| 3 years earlier | n/a | $8.48M Ended 2022-12-31 | n/a | $750.0K Ended 2023-06-30 |
| 4 years earlier | n/a | $7.05M Ended 2021-12-31 | n/a | $869.0K Ended 2022-06-30 |